The Dividend Aristocrats are among the best stocks for long-term income investors. Dividend Aristocrats have excellent business models that have produced annual dividend increases, even during recessions.

The following 3 dividend stocks have increased their payouts for over 25 consecutive years, placing them on the exclusive Dividend Aristocrats list.

They also have high expected total returns over the next five years, due to a combination of dividend yield, future earnings growth, and an expanding valuation multiple.

Roper Technologies (ROP)

Roper Technologies is a specialized industrial company that manufactures products such as medical and scientific imaging equipment, pumps, and material analysis equipment.

Roper Technologies also develops software solutions for the healthcare, transportation, food, energy, and water industries. The company was founded in 1981, generates around $7.0 billion in annual revenues, and is based in Sarasota, Florida.

On October 23rd, 2025, Roper posted its Q3 results for the period ending September 30th, 2025. Quarterly revenues and adjusted EPS were $2.02 billion and $5.14, up 14% and 11% year-over-year, respectively.

Organic growth was 6%, with acquisitions contributing 8%, reflecting continued strength across Roper’s diversified software and technology portfolio.

During the quarter, the company deployed $1.3 billion toward strategic acquisitions, including Subsplash and several bolt-on deals, while continuing to advance AI-driven innovation across its businesses.

Management modestly adjusted its full-year 2025 adjusted EPS guidance to a range of $19.90 to $19.95 (from $19.90 to $20.05 previously) to reflect minor dilution from recent acquisitions.

ROP has increased its dividend for 32 consecutive years.

Brown & Brown (BRO)

Brown & Brown Inc. is a leading insurance brokerage firm that provides risk management solutions to both individuals and businesses, with a focus on property & casualty insurance. Brown & Brown has a notably high level of insider ownership.

Brown & Brown posted third quarter earnings on October 27th, 2025, and results were better than expected. Adjusted earnings-per-share came to $1.05, which was 12 cents ahead of estimates. Revenue soared 35% year-over-year thanks to acquisitions, beating estimates by $70 million at $1.61 billion.

Commissions and fees rose 34% year-over-year, while organic revenue (which excludes acquisitions) rose 3.5%. Income before taxes was $311 million, which was off 2% year-over-year, with margin declining from 26.7% of revenue to 19.4%.

For the nine months, revenue was up 19% year-over-year to $4.3 billion, with commissions and fees up 18%. Organic revenue growth was 4.6%. Income before taxes was $1 billion, up 2%, on margin that fell from 28.4% to 24.4% of revenue. EBITDAC was $1.6 billion on EBITDAC margin that rose from 35.9% to 37.1% of revenue.

We have slightly boosted our estimate of earnings-per-share for this year to $4.20. The company also boosted its dividend for the 32nd consecutive year, raising it by 10% to a new payout of 66 cents per share annually.

Becton Dickinson & Co. (BDX)

Becton, Dickinson & Co. is a global leader in the medical supply industry. The company was founded in 1897 and has 75,000 employees across 190 countries.

The company generates about $20 billion in annual revenue, with approximately 43% of revenues coming from outside of the U.S.

Becton, Dickinson & Co., or BD, is a global leader in the medical supply industry. The company generates almost $22 billion in annual revenue, with approximately 43% of revenues coming from outside of the U.S.

BD is composed of three segments. Products sold by the Medical Division include needles for drug delivery systems, and surgical blades. The Life Sciences division provides products for the collection and transportation of diagnostic specimens. The Intervention segment includes several of the products produced by what used to be Bard.

On August 7th, 2025, BD announced results for the third quarter of fiscal year 2025, which ended June 30th, 2025. For the quarter, revenue improved 10.4% to $5.5 billion, which was $10 million more than expected.

On a currency neutral basis, revenue increased 8.5%. Adjusted earnings-per-share of $3.68 compared favorably to $3.50 in the prior year and was $0.28 more than anticipated.

For the quarter, U.S. grew 10% while international was up 11% on a reported basis. Excluding currency exchange, international was higher by 9.8%. Organic growth was higher by 3% for the period.

BDX has increased its dividend for 53 consecutive years.

Disclosure: No positions in any stocks mentioned

_______________

Bob Ciura has worked at Sure Dividend since October 2016. He oversees all content for Sure Dividend and its partner sites. Bob received a Bachelor’s degree in Finance from DePaul.